Michael Quentin

Papers

Total Citations

H-Index

About

Dr. Michael Quentin is a leading researcher in the field of urological oncology, with a primary focus on the application of advanced imaging to improve prostate cancer management. His key research areas include multiparametric magnetic resonance imaging (mpMRI), surgical oncology, and the prediction of surgical outcomes. Dr. Quentin’s major contribution is the development of MRI-based risk predictors for positive surgical margins (PSM) following robotic-assisted radical prostatectomy (RPE). His landmark 2022 study, which has garnered 24 citations, demonstrated that pre-operative 3T mpMRI can reliably identify patients at heightened risk for PSM, thereby enabling more personalized surgical planning and potentially reducing recurrence rates. This work bridges the critical gap between radiological findings and surgical decision-making, offering a non-invasive tool to improve oncological outcomes. By integrating advanced imaging into preoperative risk stratification, Dr. Quentin is helping to refine patient selection for nerve-sparing techniques and adjuvant therapies. His research continues to shape the standard of care, making him a notable figure in the effort to enhance precision in prostate cancer treatment.